The estimated Net Worth of John R Gailey is at least 19.6 百万$ dollars as of 13 November 2014. John Gailey owns over 28,000 units of West Pharmaceutical Services stock worth over 18,108,044$ and over the last 19 years John sold WST stock worth over 1,466,360$.
John has made over 8 trades of the West Pharmaceutical Services stock since 2011, according to the Form 4 filled with the SEC. Most recently John sold 28,000 units of WST stock worth 1,466,360$ on 13 November 2014.
The largest trade John's ever made was selling 28,000 units of West Pharmaceutical Services stock on 13 November 2014 worth over 1,466,360$. On average, John trades about 1,788 units every 20 days since 2005. As of 13 November 2014 John still owns at least 59,891 units of West Pharmaceutical Services stock.
You can see the complete history of John Gailey stock trades at the bottom of the page.
John's mailing address filed with the SEC is 101 GORDON DRIVE, , LIONVILLE, PA, 19341.
Over the last 19 years, insiders at West Pharmaceutical Services have traded over 32,829,857$ worth of West Pharmaceutical Services stock and bought 19,924 units worth 1,139,950$ . The most active insiders traders include Robert F Friel、Paolo Pucci、Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of 4,786,805$. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth 308,700$.
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
West Pharmaceutical Services executives and other stock owners filed with the SEC include: